| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| CCK | GCG | ENSMMUP00000001437 | ENSMMUP00000071672 | Cholecystokinin preproprotein. | Glucagon. | 0.790 |
| CCK | GHRL | ENSMMUP00000001437 | ENSMMUP00000062710 | Cholecystokinin preproprotein. | Ghrelin and obestatin prepropeptide. | 0.938 |
| CCK | INS | ENSMMUP00000001437 | ENSMMUP00000037777 | Cholecystokinin preproprotein. | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.806 |
| CCK | LEP | ENSMMUP00000001437 | ENSMMUP00000007035 | Cholecystokinin preproprotein. | Leptin; Key player in the regulation of energy balance and body weight control. Once released into the circulation, has central and peripheral effects by binding LEPR, found in many tissues, which results in the activation of several major signaling pathways (By similarity). In the hypothalamus, acts as an appetite-regulating factor that induces a decrease in food intake and an increase in energy consumption by inducing anorexinogenic factors and suppressing orexigenic neuropeptides, also regulates bone mass and secretion of hypothalamo-pituitary-adrenal hormones. In the periphery, inc [...] | 0.818 |
| CCK | NPY2R | ENSMMUP00000001437 | ENSMMUP00000018630 | Cholecystokinin preproprotein. | Neuropeptide Y receptor type 2; Receptor for neuropeptide Y and peptide YY; Belongs to the G-protein coupled receptor 1 family. | 0.576 |
| CCK | POMC | ENSMMUP00000001437 | ENSMMUP00000075833 | Cholecystokinin preproprotein. | Uncharacterized protein. | 0.859 |
| CCK | PYY | ENSMMUP00000001437 | ENSMMUP00000012710 | Cholecystokinin preproprotein. | Uncharacterized protein. | 0.920 |
| GCG | CCK | ENSMMUP00000071672 | ENSMMUP00000001437 | Glucagon. | Cholecystokinin preproprotein. | 0.790 |
| GCG | GHRL | ENSMMUP00000071672 | ENSMMUP00000062710 | Glucagon. | Ghrelin and obestatin prepropeptide. | 0.951 |
| GCG | INS | ENSMMUP00000071672 | ENSMMUP00000037777 | Glucagon. | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.952 |
| GCG | LEP | ENSMMUP00000071672 | ENSMMUP00000007035 | Glucagon. | Leptin; Key player in the regulation of energy balance and body weight control. Once released into the circulation, has central and peripheral effects by binding LEPR, found in many tissues, which results in the activation of several major signaling pathways (By similarity). In the hypothalamus, acts as an appetite-regulating factor that induces a decrease in food intake and an increase in energy consumption by inducing anorexinogenic factors and suppressing orexigenic neuropeptides, also regulates bone mass and secretion of hypothalamo-pituitary-adrenal hormones. In the periphery, inc [...] | 0.928 |
| GCG | POMC | ENSMMUP00000071672 | ENSMMUP00000075833 | Glucagon. | Uncharacterized protein. | 0.716 |
| GCG | PYY | ENSMMUP00000071672 | ENSMMUP00000012710 | Glucagon. | Uncharacterized protein. | 0.854 |
| GHRL | CCK | ENSMMUP00000062710 | ENSMMUP00000001437 | Ghrelin and obestatin prepropeptide. | Cholecystokinin preproprotein. | 0.938 |
| GHRL | GCG | ENSMMUP00000062710 | ENSMMUP00000071672 | Ghrelin and obestatin prepropeptide. | Glucagon. | 0.951 |
| GHRL | INS | ENSMMUP00000062710 | ENSMMUP00000037777 | Ghrelin and obestatin prepropeptide. | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.985 |
| GHRL | LEP | ENSMMUP00000062710 | ENSMMUP00000007035 | Ghrelin and obestatin prepropeptide. | Leptin; Key player in the regulation of energy balance and body weight control. Once released into the circulation, has central and peripheral effects by binding LEPR, found in many tissues, which results in the activation of several major signaling pathways (By similarity). In the hypothalamus, acts as an appetite-regulating factor that induces a decrease in food intake and an increase in energy consumption by inducing anorexinogenic factors and suppressing orexigenic neuropeptides, also regulates bone mass and secretion of hypothalamo-pituitary-adrenal hormones. In the periphery, inc [...] | 0.986 |
| GHRL | NPY1R | ENSMMUP00000062710 | ENSMMUP00000080517 | Ghrelin and obestatin prepropeptide. | Neuropeptide Y receptor type 1; Belongs to the G-protein coupled receptor 1 family. | 0.797 |
| GHRL | NPY2R | ENSMMUP00000062710 | ENSMMUP00000018630 | Ghrelin and obestatin prepropeptide. | Neuropeptide Y receptor type 2; Receptor for neuropeptide Y and peptide YY; Belongs to the G-protein coupled receptor 1 family. | 0.778 |
| GHRL | POMC | ENSMMUP00000062710 | ENSMMUP00000075833 | Ghrelin and obestatin prepropeptide. | Uncharacterized protein. | 0.887 |
